June 15, 2022
The Ministry of Health, Labor and Welfare (MHLW) on June 14 ordered label revisions for nine drugs including the addition of anaphylaxis risks for two COVID-19 pills Lagevrio (molnupiravir) and Paxlovid (nirmatrelvir/ritonavir), respectively developed by MSD and Pfizer. In the...read more